03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *
Lanoxin Ampoules* : | |
Type | Medicine Non Marketed |
Originator | B |
Agent | Abela Freres |
Distributor | Abela Freres |
Laboratory | GSK |
Responsible Party | The Wellcome Foundation Ltd |
Origin | UK |
Manufacturer | The Wellcome Foundation Ltd |
Origin | UK |
ATC | C01AA05 |
Lanoxin Ampoules* :
Lanoxin Ampoules* :
Lanoxin Ampoules* :
Lanoxin Ampoules* :
Lanoxin Ampoules* :
Hazard Level |
---|
◼ Major |
◼ Moderate |
◼ Minor |
◼ Safe |
Lanoxin Ampoules* :
Frequency | Percentage |
---|---|
Very Common | ≥ 1/10 |
Common | ≥ 1/100 - < 1/10 |
Uncommon | ≥ 1/1,000 - < 1/100 |
Rare | ≥ 1/10,000 - < 1/1,000 |
Very Rare | < 1/10,000 |
Unknown | Cannot be Estimated |
Effect | Frequency |
---|---|
Anorexia | Very rare |
Apathy | Very rare |
Arrhythmia | Common |
Atrial tachycardia | Very rare |
Bigeminy | Common |
Central nervous system disorder | Common |
Conduction disorders | Common |
Confusion | Very rare |
Depression | Uncommon |
Diarrhoea (Diarrhea) | Common |
Dizziness | Common |
ECG ST segment depression | Very rare |
Eosinophilia | Common |
Fatigue | Very rare |
Gynecomastia (Gynaecomastia) | Very rare |
Headache | Very rare |
Intestinal ischaemia | Very rare |
Intestinal necrosis | Very rare |
Junctional tachycardia | Very rare |
Malaise | Very rare |
Nausea | Common |
PR interval prolonged | Common |
Premature ventricular contractions | Very rare |
Psychosis | Very rare |
Sinus bradycardia | Common |
Skin rash | Common |
Supraventricular tachyarrhythmia | Very rare |
Thrombocytopenia (Thrombopenia) | Very rare |
Trigeminy | Common |
Ventricular arrhythmia | Very rare |
Vision blurred | Common |
Visual disturbance | Common |
Vomiting | Common |
Weakness | Very rare |
NB : Products With Same Indication |
Different Units By MoH Code
Lanoxin Ampoules* MoH 663 :
Form | Solution for injection |
Packaging | Glass Ampoules |
Package Size | 5x2ml |
Strength | 0.5mg |
NSSF | ✘ |
Quarantine | ✘ |
Reg. Number | 2106/72 |
Submission date | 01/01/1972 |
Registration Year | 1972 |
Archived Date | 2014 |
Price Comparison
You have to register to view this info
Drop File